UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011230
Receipt No. R000013157
Scientific Title Phase II Clinical trial of personalized peptide vaccine for patients with maligant tumors (gastrointestinal cancers, hepato-biliary-pancreatic cancers, thoracic malignant tumors, non-epithelial malignant tumors, genitourinary cancers, gynecological cancers, breast cancers, and rare cancers) - Effect of extended interval dosing on immune responses -
Date of disclosure of the study information 2013/07/23
Last modified on 2019/01/07 11:08:22

No. Disposal Last modified on Item of update
1 Insert 2013/07/19 15:36:42
2 Update 2014/07/14 17:13:44 Email
3 Update 2014/12/12 12:22:15
Key inclusion criteria
Key inclusion criteria
4 Update 2019/01/07 11:08:22 Recruitment status


Contact us.